|
Originally published In Press as doi:10.1074/jbc.M206793200 on August 6, 2002
J. Biol. Chem., Vol. 277, Issue 43, 40981-40988, October 25, 2002
Stalk Segment 5 of the Yeast Plasma Membrane
H+-ATPase
LABELING WITH A FLUORESCENT MALEIMIDE REVEALS A CONFORMATIONAL
CHANGE DURING GLUCOSE ACTIVATION*,
Manuel
Miranda ,
Juan Pablo
Pardo§,
Kenneth E.
Allen, and
Carolyn W.
Slayman
From the Departments of Genetics and Cellular & Molecular
Physiology, Yale University School of Medicine, New Haven,
Connecticut 06510
Received for publication, July 8, 2002, and in revised form, July 31, 2002
 |
ABSTRACT |
Glucose is well known to cause a rapid,
reversible activation of the yeast plasma membrane
H+-ATPase, very likely mediated by phosphorylation of
two or more Ser/Thr residues near the C terminus. Recent
mutagenesis studies have shown that glucose-dependent
activation can be mimicked constitutively by amino acid substitutions
in stalk segment 5 (S5), an -helical stretch connecting the
catalytic part of the ATPase with transmembrane segment 5 (Miranda, M.,
Allen, K. E., Pardo, J. P., and Slayman, C. W. (2001)
J. Biol. Chem. 276, 22485-22490). In the present work, the fluorescent maleimide Alexa-488 has served as a probe for
glucose-dependent changes in the conformation of S5.
Experiments were carried out in a "3C" version of the ATPase, from
which six of nine native cysteines had been removed by site-directed
mutagenesis to eliminate background labeling by Alexa-488. In this
construct, three of twelve cysteines introduced at various positions
along S5 (A668C, S672C, and D676C) reacted with the Alexa dye in a
glucose-independent manner, as shown by fluorescent labeling of the 100 kDa Pma1 polypeptide and by isolation and identification of the
corresponding tryptic peptides. Especially significant was the fact
that three additional cysteines reacted with Alexa-488 more rapidly
(Y689C) or only (V665C and L678C) in plasma membranes from
glucose-metabolizing cells. The results support a model in which the S5
-helix undergoes a significant change in conformation to expose
positions 665, 678, and 689 during glucose-dependent
activation of the ATPase.
 |
INTRODUCTION |
P2-type ATPases are a widespread family of cation
pumps found throughout prokaryotic and eukaryotic cells (1). Actively studied members of the family include the plasma membrane
H+-ATPases of yeast, Neurospora, and higher
plants, as well as the Na+,K+-;
H+,K+-; and Ca2+-ATPases of animal
cells. All of these examples are abundant membrane proteins, and in
many cases they hydrolyze 25% or more of total cellular ATP
(e.g. 2). It is thus not surprising that regulatory mechanisms have evolved to adjust ATPase activity to the physiological needs of the cell.
The yeast plasma membrane H+-ATPase, which is encoded by
the PMA1 gene (3), has been known for almost two decades to
be strongly regulated by glucose (4). When yeast cells are placed in
carbon-free medium, there is a rapid, 5- to 10-fold decrease in Pma1
ATPase activity, and when glucose is added back, activity rebounds
completely in less than 5 min. Although the mechanism is not yet fully
understood, there is growing evidence to implicate the C terminus of
the ATPase, acting as an autoinhibitory domain (reviewed in Ref. 5).
Mutations at two potential phosphorylation sites within this region,
Ser-899 and Thr-912, affect the ability of glucose to stimulate ATPase
activity (6), and thermolysin digests of the 100-kDa
H+-ATPase polypeptide have revealed two (as yet
unidentified) phosphopeptides that decrease in amount during carbon
starvation and increase again upon glucose addition (7). Thus, it has
been proposed that the C terminus becomes dephosphorylated during
carbon starvation, allowing it to interact in an inhibitory way with
one or more catalytically important parts of the ATPase; upon addition
of glucose, the C terminus is rephosphorylated, and the inhibition is
released (5, 8).
Recently, genetic evidence has suggested that stalk segment 5 (S5)1 of the
H+-ATPase polypeptide may take part in this regulatory
interaction. S5, which stretches from Pro-669 to Tyr-689, is one of
several -helical segments that connect the cytoplasmic domains of
the ATPase to the membrane-embedded domain. The overall shape of the stalk was first seen by cryoelectron microscopy of the
Neurospora plasma membrane H+-ATPase and the
sarcoplasmic reticulum Ca2+-ATPase (9, 10); a 2.6 Å x-ray
crystallographic structure of the latter enzyme has since provided a
high-resolution view (11). Remarkably, S5 and its related transmembrane
segment (M5) appear as a continuous -helix, 60 Å long, around which
the rest of the polypeptide is organized. It was thus of considerable
interest when scanning mutagenesis of S5 identified seven periodically spaced positions at which single amino acid substitutions led to
strong, constitutive activation of the yeast H+-ATPase
(Phe-666, Leu-671, Ile-674, Ala-677, Ile-684, Arg-687, Tyr-689, Ref.
12). At each of these positions, which lie along one face of the
-helix, replacement by a Cys residue increased ATPase activity in
starved cells to levels usually seen only in glucose-metabolizing
cells. Furthermore, at two additional positions on the same face of S5,
Portillo and co-workers (13) have described mutations that suppress the
effect of amino acid substitutions at Ser-899 and Thr-912 in the C terminus.
With this information as background, the present study was designed to
look directly at S5 of the yeast Pma1 H+-ATPase, using a
fluorescent maleimide (Alexa-488) to probe the previously constructed
set of Cys mutants (12). The goal was to identify cysteines that can
react with Alexa-488 and to ask whether reactivity varies with
experimental conditions in a way that might signal a
glucose-dependent conformational change in or near S5.
 |
EXPERIMENTAL PROCEDURES |
Yeast Strains--
Two strains of Saccharomyces
cerevisiae were used in this study: SY4
(MATa, ura3-52, leu2-3,112, his4-619,
sec6-4ts GAL2,
pma1::YIpGAL-PMA1) and NY13
(MATa, ura3-52). In strain SY4, the
chromosomal copy of the PMA1 gene has been placed under
control of the GAL1 promotor by gene disruption (14) using the integrating plasmid, YIpGAL-PMA1 (15). SY4 also carries the
temperature-sensitive sec6-4 mutation which, upon incubation at 37 °C, blocks the fusion of secretory vesicles with the plasma membrane (16).
Preparation of S5 Mutants--
Yeast strains bearing Cys
substitutions in stalk segment 5 of the Pma1 ATPase have been described
previously (12). For the present study, the
BglII-SalI restriction fragment carrying each mutation was moved into a modified version of plasmid pPMA1.2 (15) or
plasmid pGW201 (17). Both plasmids were designed to add a 10-histidine
tag to the N terminus of the ATPase and to replace all but three of the
nine original Cys residues (Cys-376, Cys-409, and Cys-472) with Ala. To
express the mutant ATPase in secretory vesicles, the 3.8-kb
HindIII-SacI fragment from PMA1.2-3C, which
contains the entire pma1 coding region, was cloned into the
yeast expression vector YCp2HSE (15), placing the mutant allele under
control of two tandemly arranged heat-shock elements. Plasmids were
then transformed into yeast according to the method of Ito et
al. (18). To integrate the Cys mutations into the chromosomal copy
of the PMA1 gene, the 6.1-kb HindIII fragment from pGW201-3C, containing the mutant allele linked to URA3,
was excised from the plasmid and transplaced into strain NY13 using the
Alkali-Cation Yeast transformation kit (Bio 101). In both cases, the
presence of the desired mutation was confirmed by DNA sequencing.
Isolation of Secretory Vesicles and Plasma
Membranes--
Secretory vesicles were prepared from SY4-derived
strains by the method of Ambesi et al. (19) and suspended in
0.8 M sorbitol, 1 mM EDTA, 10 mM
TEA/acetic acid, pH 7.2. To isolate plasma membranes from
glucose-starved and glucose-metabolizing cells, NY13-derived strains
were grown to mid-exponential phase in supplemented minimal medium
containing 4% glucose, washed, and incubated with or without glucose
as described by Miranda et al. (12), A microsomal membrane fraction was then prepared by the method of Perlin et al.
(20), washed with 1 mM EGTA/Tris, and resuspended in a
small volume of the same buffer. All procedures were carried out at
0-4 °C.
ATP Hydrolysis--
Unless otherwise noted, ATP hydrolysis was
assayed at 30 °C in 0.5 ml of 50 mM MES/Tris, pH 5.7 or
6.25, 5 mM KN3, 5 mM
Na2ATP, 10 mM MgCl2, and an ATP
regenerating system (5 mM phosphoenolpyruvate and 50 µg/ml pyruvate kinase). The reaction was terminated after 20-40 min
with 50 µl of 30% trichloroacetic acid, and the release of inorganic
phosphate from ATP was determined by the method of Fiske and Subbarow
(21). Specific activity was calculated as the difference between ATP
hydrolysis in the absence and in the presence of 100 µM
sodium orthovanadate, a potent inhibitor of P-type ATPases.
Exposure to Alexa-488--
To examine the reactivity of the
introduced Cys residues, Alexa-488 (Alexa-Fluor-488 C5
maleimide sodium salt; Molecular Probes) was used as a probe. Secretory
vesicles were suspended at a protein concentration of 1 mg/ml in 0.8 M sorbitol, 1 mM EDTA, 10 mM TEA, pH 7.2; plasma membranes were suspended at a protein concentration of
0.5 mg/ml in 50 mM HEPES, pH 7.0. In both cases, Alexa-488 was added from a fresh stock solution to a final concentration of 1 mM, and the suspension was incubated at 30 °C. Aliquots
were removed at intervals and diluted 100-fold into ATPase reaction mixture containing 1 mM -mercaptoethanol. Inorganic
phosphate was determined as described above (21). The rate constants
for inactivation were calculated by fitting the data to Equations 1 and
2,
|
(Eq. 1)
|
|
(Eq. 2)
|
when Alexa-488 brought about a monophasic or biphasic, complete
inactivation of the ATPase, or to Equation 3,
|
(Eq. 3)
|
when inactivation was not complete. A0,
k, and F correspond to the activity at zero time, the
pseudo-first order rate constant of inactivation, and the final
residual activity, respectively.
Labeling of the ATPase with Alexa-488 was carried out under native and
denatured conditions. To label the native enzyme, secretory vesicles
and plasma membranes were suspended as described above. In both cases,
Alexa-488 was added to a final concentration of 1 mM, and
the suspension was incubated for either 8 or 20 min at 30o.
The reaction was stopped by 30-fold dilution into 5 mM
HEPES, 10% glycerol, 20 mM -mercaptoethanol, pH 7.5. The membranes were centrifuged at 100,000 × g for 35 min and resuspended in 1 ml of 20 mM Tris, 300 mM NaCl, 5 mM -mercaptoethanol, pH 8.0. The ATPase was then solubilized by the addition of 0.5% SDS and purified by Ni-NTA affinity chromatography as described below.
For complete labeling of sulfhydryl groups in the ATPase,
secretory vesicles (1 mg/ml) or plasma membranes (0.5 mg/ml)) were first denatured with 1% SDS and then exposed to 1 mM
Alexa-488 for 60 min at 30 °C. The reaction was stopped by the
addition of 20 mM -mercaptoethanol, and the ATPase was
purified by Ni-NTA affinity chromatography.
Purification of His-tagged ATPase by Ni-NTA Affinity
Chromotography--
To purify the ATPase, the SDS-solubilized membrane
fraction was mixed with 0.5 ml of Ni-NTA previously equilibrated with
20 mM Tris, pH 8.0, 300 mM NaCl, and 5 mM -mercaptoethanol, and incubated at room
temperature for 1 h with continuous shaking. The mixture was then
transferred to a disposable column (Poly-Prep Chromatography colums,
Bio-Rad), the flow-through was discarded, and the column washed with 20 ml of 10 mM Tris, 25 mM
Na2HPO4, 20 mM imidazole, 200 mM NaCl, 0.1% SDS, pH 8.0. Finally, the His-tagged ATPase
was eluted with 0.3-0.5 ml of 10 mM Tris, 25 mM Na2HPO4, 250 mM
imidazole, 200 mM NaCl, 0.1% SDS, pH 6.3.
Trypsinolysis and Peptide Isolation--
Purified ATPase was
concentrated to 50-100 µl with a Biomax-30K filter (Millipore) and
precipitated with 4 volumes of cold acetone. The protein was collected
by centrifugation, and the pellet was suspended in 0.15 ml of 2 M urea, 0.15 M NH4HCO3,
pH 8.0. The ATPase was then digested with trypsin (2.5 µg) for 4 h at 30 °C and for a further 2 h after a second addition of
trypsin (2.5 µg). At the end of the incubation, trypsinolysis was
stopped by the addition of 1 mM DFP.
To separate labeled peptides by HPLC, the tryptic digest was injected
into a Vydac C18 column and eluted with a gradient of 0-80% acetonitrile in 0.005% trifluoroacetic acid as described previously (22). The absorbance of the eluate was measured at 210 nm to
detect all peptides and at 493 nm to detect Alexa-labeled peptides.
Peptides were purified using either a C18 aquapore column with the same acetonitrile gradient or the original C18
Vydac column with a different gradient. N-terminal amino acid sequences of the purified fluorescent peptides were determined by MALDI-MS and/or
Edman degradation. HPLC, mass spectrometry, and peptide sequencing were
performed in Yale University's Keck Foundation Biotechnology Resource Laboratory.
Protein Determination--
Protein concentrations were
determined by the method of Lowry et al. (23) as modified by
Ambesi et al. (19), with bovine serum albumin as standard.
 |
RESULTS |
Design of Experiments--
As described in the Introduction, the
initial goal of this study was to ask whether Alexa-488 can react with
any of the Cys residues previously introduced into stalk segment 5. For
this purpose, we began with a well characterized expression system that
uses a temperature-sensitive mutation in the SEC6 gene to arrest newly synthesized H+-ATPase in secretory vesicles,
just prior to fusion with the plasma membrane (15). Because the
vesicles are oriented inside-out, the impermeant Alexa dye should in
principle have access to cytoplasmically exposed regions of the
H+-ATPase, including S5 (Fig.
1).

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 1.
Two-dimensional map of the yeast Pma1
H+-ATPase. Stalk segment 5 (S5) is highlighted, as are
the three cysteine residues present in the 3C version of the ATPase
that was used in this study (Cys-376, Cys-409, Cys-472).
|
|
In an early control experiment, wild-type ATPase was tagged with 10 histidine residues at the N terminus to allow for subsequent purification (24); it was then expressed in secretory vesicles and
exposed to 1 mM Alexa-488 for 0-10 min. The ATPase was
rapidly inactivated under these conditions (Fig.
2A), indicating that one or
more of its 9 native cysteines must be reactive with Alexa-488. We
therefore turned to the set of mutant strains constructed by Petrov and
Slayman (25), in which varying numbers of native Cys residues were
replaced by Ala or Ser. In that study, a totally Cys-free
H+-ATPase was found to possess little or no enzymatic
activity in secretory vesicles, and versions containing one or two
cysteines were markedly less active than the wild-type control.
However, a mutant with three cysteines (Cys-376, Cys-409, and Cys-472; see Fig. 1) was able to split ATP and pump protons at close to 80% of
the wild-type rate.2
Furthermore, in the experiment of Fig. 2A, the His-tagged
version of this 3C construct proved to be virtually insensitive to
Alexa-488. It was thus well suited for the present study.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 2.
Time course of inactivation by Alexa-488 in
secretory vesicles. Secretory vesicles containing wild-type
(WT), 3C, A668C, S672C, or D676C H+-ATPase were
incubated with 1 mM Alexa for 0-20 min and assayed for
H+-ATPase activity as described under "Experimental
Procedures." The data represent the average for 2-4 independent
vesicle preparations, and the lines were drawn by least-squares
analysis.
|
|
As a critical control, secretory vesicles containing His-tagged, 3C
H+-ATPase were incubated with Alexa-488 for 8 min. The
ATPase was then solubilized, purified by Ni-NTA affinity
chromatography, digested with trypsin, and analyzed by HPLC. None of
the three cysteines was significantly labeled under these conditions
(Fig. 3, panel B), even though
labeled peptides corresponding to all three could be readily identified
in ATPase that had been denatured with SDS before exposure to the Alexa
dye (Fig. 3, panel A and Table
I). Thus, Cys-376, Cys-409, and Cys-472
do not react appreciably with Alexa-488 in the native, fully folded
ATPase, and the His-tagged 3C construct could be adopted as background
for all of the experiments to be described.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 3.
HPLC separation of peptides labeled with
Alexa-488. To label all Cys residues completely, secretory
vesicles expressing 3C ATPase (panel A) or D676C ATPase
(panel C) were incubated with 1 mM Alexa-488 in
the presence of 1% SDS for 1 h at 30 °C. To label only Cys
residues that are accessible in the native state, vesicles with 3C
ATPase (panel B) or D676C ATPase (panel D) were
exposed to Alexa-488 for 8 min in the absence of SDS. In all cases, the
reaction was stopped by the addition of 20 mM
-mercaptoethanol, and the ATPase was purified and digested with
trypsin as described under "Experimental Procedures."
Peptides were separated by HPLC, and labeling with Alexa-488 was
detected at 493 nm.
|
|
Reactivity of A668C, S672C, and D676C with Alexa-488 in Secretory
Vesicles--
The recent study by Miranda et al. (12)
yielded a complete set of mutant H+-ATPases with Cys
substitutions at individual positions along stalk segment 5. When these
mutations were placed one at a time into the His-tagged 3C background
and the mutant ATPases were expressed in secretory vesicles, 12 of them
had sufficient activity to be studied further: V665C, A668C, S672C,
A673C, D676C, L678C, K679C, T680C, Q683C, H686C, M688C, and Y689C.
Fortunately, these 12 cysteines were scattered throughout the length of
S5, where in principle they could give useful information about
structure and reactivity.
To look directly at the reactivity of the S5 cysteines, secretory
vesicle preparations were incubated with 1 mM Alexa-488 for
8 or 20 min. The mutant ATPases were then purified and subjected to
SDS-polyacrylamide gel electrophoresis, and the 100-kDa ATPase band was
analyzed for fluorescence (Fig. 4).
Consistent with the results described above, native 3C ATPase was
essentially unreactive under these conditions. When its labeling was
compared with that of denatured 3C enzyme, which was assumed to contain
3.0 mol of Alexa dye per mol of 100-kDa polypeptide (lane
1), the corresponding stoichiometry was only 0.1 for native 3C
ATPase after 8 min of incubation (lane 5) and 0.2 after 20 min of incubation (lane 7).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 4.
Labeling of the 100 kDa H+-ATPase
by Alexa-488 in secretory vesicles. Secretory vesicles expressing
3C, A668C, S672C, or D676C ATPase were incubated with 1 mM
Alexa-488 under denaturing conditions for 1 h (lanes
1-4) or under native conditions for 8 min (lanes 5-6)
or 20 min (lanes 7-9), as described under "Experimental
Procedures." Labeled ATPase was then purified by Ni-NTA
chromatography and analyzed by SDS-PAGE. A,
fluorescence of the 100-kDa band as a measure of labeling by Alexa-488;
B, Coomassie-stained 100-kDa band; C,
stoichiometry of Alexa-488 labeling (mol/mol of 100-kDa polypeptide),
calculated as described in the text.
|
|
Most reactive among the cysteines introduced into stalk segment 5 was
D676C. This residue could be completely labeled to a stoichiometry of
1.1 in only 8 min (lane 6). Two other cysteines, A668C and
S672C, reacted more slowly, reaching stoichiometries of 1.0 and 1.1 after 20 min (lanes 8 and 9). The remaining nine cysteines displayed little if any reactivity with Alexa-488 (not shown). As expected, denaturation of the mutant ATPases before exposure
to Alexa-488 gave stoichiometries corresponding to 4 Cys residues per
mol of 100-kDa polypeptide (lanes 2-4).
To confirm the identity of the labeled residues, the mutant ATPases
were purified, digested with trypsin, and analyzed by HPLC. As shown in
Fig. 3D, a new fluorescent peptide (peak 4) was seen in the
digest of D676C ATPase that had been exposed to Alexa-488 under native
conditions; the same peptide was also labeled under denaturing
conditions (Fig. 3C). This peptide was identified by
N-terminal sequence analysis as Ser-660-Lys-679 (Table I, peptide 4).
Corresponding results were obtained for A668C and S672C (not shown).
A parallel set of experiments was carried out to examine the effect of
Alexa-488 on ATPase activity. As illustrated in Fig. 2D and
Table II, D676C ATPase was rapidly
inhibited by the Alexa dye, with a rate constant of 0.757 min 1. Interestingly, the inhibition was not complete;
~40% residual activity remained even after 8 min of exposure. As
expected based on the time course of labeling, the A668C and S672C
ATPases were inhibited much more slowly, with rate constants of 0.028 and 0.063 min 1, respectively (Fig. 2, B and
C and Table II). The inhibition of S672C approached
completion at the later time points, while ~70% residual activity
remained in A668C. The remaining nine mutants had negligible rate
constants of inactivation (0.002-0.013 min 1), similar to
the 3C control (0.007 min 1).
View this table:
[in this window]
[in a new window]
|
Table II
Effect of cysteine substitutions on ATPase expression, activity, and
inhibition by Alexa-488: studies in secretory vesicles
|
|
Thus, in the secretory vesicle form of the H+-ATPase, three
of the Cys residues introduced into stalk segment 5 could clearly react
with Alexa-488, and modification led to partial (A668C, D676C) or
complete (S672C) inhibition of ATPase activity.
Glucose-dependent Reactivity of V665C, L678C, and Y689C
at the Plasma Membrane--
The next step was to ask whether Cys-668,
Cys-672, Cys-676, or any of the other Cys residues placed along stalk
segment 5 might undergo glucose-dependent changes in
reactivity with Alexa-488. For this purpose, it was necessary to
express the mutant ATPases at the plasma membrane, where glucose
regulation is known to have its full effect. Accordingly, the
chromosomal copy of the PMA1 coding sequence was replaced
with each of the His-tagged, 3C mutant constructs described above. Gene
replacement was carried out in cells possessing a normal copy of the
SEC6 gene, so when the mutant ATPase was expressed
constitutively under control of the PMA1 promoter, it could
move uninterruptedly from its site of synthesis in the endoplasmic
reticulum to the plasma membrane. As expected, all 12 mutant ATPases,
which had specific activities in secretory vesicles ranging from 28 to
72% of the wild-type level (Table II), were able to support normal or
near normal growth.
In the experiment of Table III, plasma
membranes were prepared from glucose-starved and glucose-metabolizing
cells expressing each of the His-tagged, 3C-based mutant alleles, and
assayed for ATPase activity. As found previously for untagged, 9C-based
constructs (12), Y689C was constitutively activated at the plasma
membrane, hydrolyzing ATP equally well under glucose-starved and
glucose-metabolizing conditions (14.60 and 14.46 units/mg). All but one
of the other mutants gave activation ratios between 2.0 and 5.1, and
thus were clearly regulated by glucose. A673C was intermediate in its
behavior, with an activation ratio of 1.4.
View this table:
[in this window]
[in a new window]
|
Table III
Effect of cysteine substitutions on ATPase expression, activity, and
inhibition by Alexa-488: studies on plasma membranes from
glucose-starved and glucose-metabolizing cells
|
|
With this background information in hand, the next step was to examine
the reactivity of S5 Cys residues with Alexa-488 in plasma membranes
from glucose-starved and glucose-metabolizing cells (Fig.
5). Not surprisingly, the three cysteines
already found to react with Alexa-488 in secretory vesicles (A668C,
S672C, D676C; see above) gave comparable results in plasma membranes, and the stoichiometry of labeling under glucose-starved conditions (1.0-1.2; see lanes 9, 11, and
13) was very close to that under glucose-metabolizing
conditions (1.4-1.5; see lanes 10, 12, and 14). Strikingly, however, three additional mutant ATPases
became labeled by Alexa-488 in plasma membranes, but only when the
membranes were prepared from glucose-metabolizing cells. They were
V665C, L678C, and Y689C, which reached stoichiometries of 1.2, 0.8, and 1.4, respectively, in glucose-metabolizing preparations (Fig. 5,
lanes 8, 16, and 18). By
contrast, the values in glucose-starved preparations were only 0.1-0.3
(lanes 7, 15, and 17), similar to
those seen in the 3C control (0.1; lanes 3 and
5).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
Labeling of the 100 kDa H+-ATPase
by Alexa-488 in plasma membranes. Plasma membranes were isolated
from glucose-starved or glucose-metabolizing 3C, V665C, A668C, S672C,
D676C, L678C, or Y689C cells, and incubated with 1 mM
Alexa-488 under native conditions for 8 min (lanes 3 and
4, 13-16) or 20 min (lanes 5-12,
17 and 18), as described under "Experimental
Procedures." To allow quantitation of labeling, 3C membranes were
also incubated with 1 mM Alexa-488 for 1 h under
denaturing conditions (lanes 1 and 2). Labeled
ATPase was then purified and analyzed by SDS-PAGE. A,
fluorescence of the 100-kDa band as a measure of labeling by Alexa-488;
B, Coomassie-stained 100-kDa band; C,
stoichiometry of Alexa-488 labeling (mol/mol 100-kDa polypeptide),
calculated as described in the text.
|
|
To verify the identity of the Alexa-reactive Cys residues in these
three mutants, labeled ATPase was digested with trypsin and analyzed by
HPLC. In two cases (V665C and L678C), a new fluorescent peptide was
seen and identified by Edman degradation as Ser-660-Lys-679 (Table I).
No fluorescent peak was found for Y689C, presumably because the
corresponding peptide (Met-668-Arg-695) was too hydrophobic to be
isolated under the experimental conditions that were used.
Once again, parallel measurements were carried out to ask whether
hydrolytic activity was affected by modification with Alexa-488. As
already seen in secretory vesicles, the A668C, S672C, and D676C ATPases
were clearly inactivated by Alexa dye at the plasma membrane (Table
III). Worth noting is the fact that all three mutants displayed higher
rate constants of inactivation under glucose-starved conditions than
under glucose-metabolizing conditions. Because a similar effect was
seen in the wild-type and 3C controls and in all but two of the other
mutants, the most likely explanation is a conformational change
affecting one or more of the native cysteines.
The most significant result in Table III is that
glucose-dependent modification of Cys-665, Cys-678, and
Cys-689 by Alexa-488 had virtually no effect on ATPase activity. The
rate constants of inactivation were very low in both glucose-starved
and glucose-metabolizing samples: 0.029 and 0.014 min 1
for V665C, 0.035 and 0.025 min 1 for L678C, and 0.001 and
0.003 min 1 for Y689C, similar to the values seen in the
3C control (0.025 and 0.013 min 1) (Table III). Thus,
unlike the situation for positions 668, 672, and 676, the addition of
the bulky Alexa group at positions 665, 678, and 689 had little or no
effect on the catalytic properties of the H+-ATPase
 |
DISCUSSION |
In this study, Alexa-488 has been used as a fluorescent probe to
examine the role of stalk segment 5 in the
glucose-dependent activation of yeast Pma1
H+-ATPase. Several conclusions can be drawn from the
results. First, because Alexa-488 is known to be membrane-impermeant
(26), its ability to reach Cys residues at positions 668, 672, and 676 in inside-out secretory vesicles confirms that, as expected, stalk segment 5 is located on the cytoplasmic side of the membrane. More
significant is the fact that these three cysteines were modified by
Alexa dye under all of the experimental conditions tested: before and
after the ATPase had reached the plasma membrane, and before and after
it had been fully activated by glucose. In a helical-wheel diagram,
A668C, S672C, and D676C lie on one face of S5 (Fig.
6, open rectangles) which,
because it is accessible to Alexa-488, is presumably exposed to the
aqueous medium. Indeed, when the Pma1 H+-ATPase was aligned
with SERCA1 Ca2+-ATPase and modeled using the SERCA
structure (11) as a template, Ala-668, Ser-672, and Asp-676 all
appeared at the protein surface (Fig.
7A).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 6.
Helical wheel diagram of S5. Positions
at which amino acid substitutions have led to glucose-independent
activation of the yeast H+-ATPase (12, 13) are represented
by gray rectangles, and residues labeled by Alexa-488 are
represented by open rectangles.
|
|

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 7.
Model of the yeast Pma1 ATPase, showing the
location of Alexa-reactive residues and residues involved in
glucose-dependent regulation. The yeast Pma1p sequence
was aligned with the SERCA ATPase sequence, and modeled using the
Swiss-Model server of GlaxoSmithKline R&D (Geneva). Panels A
and B, spacefill display, illustrating positions
at which Cys substitutions reacted with Alexa-488 under all conditions
(red) or only under glucose-metabolizing conditions
(blue). Note that Ala-668, Ser-672, and Asp-676 are visible
at the surface of the protein, and Val-665 and Leu-678 are buried;
Tyr-689, while exposed to the surface, is located at the base of a
cavity. Panel C, ribbon display with the P-domain
highlighted in green and S5 in red. Panel
D, closer view of the P-domain and S5; positions at which
mutations led to a constitutively activated enzyme are highlighted in
black.
|
|
By contrast, the opposite face of the S5 helix is defined by residues
previously shown to be involved in the activation of Pma1 ATPase by
glucose. These residues include Phe-666, Leu-671, Ile-674, Ala-677,
Ile-684, Arg-687, and Tyr-689 (12) and Pro-669 and Gly-670 (13), marked
by gray rectangles in the helical-wheel diagram of Fig. 6. The first
seven are positions at which substitution by Cys led to constitutive
activation, suggesting that the mutations had somehow interfered with
the ability of the starvation signal (presumably, dephosphorylation of
the C terminus, Ref. 5) to down-regulate enzyme turnover. The other two
positions (Pro-669 and Gly-670) are sites of suppressor mutations that
also result in constitutive activation (13). In the three-dimensional
structural model of the Pma1 ATPase, all nine residues are located in
the interior of the protein (Fig. 7D). Six of them are
closely associated with the mechanistically essential P
(phosphorylation) domain, while the other three lie at the interface of
S5 with the membrane and interact with stalk segment 4 (S4).
In sharp contrast to A668C, S672C, and D676C are three other cysteines,
V665C, L678C, and Y689C, which had little or no ability to react with
Alexa-488 in secretory vesicles or in plasma membranes from
glucose-starved cells, but gained the ability to react in plasma
membranes from glucose-metabolizing cells. One obvious possibility is
that the autoinhibitory C terminus shields all three residues under the
former conditions, but becomes phosphorylated and moves aside under the
latter conditions. Given the complete absence of homology between the
C-terminal domains of the Pma1 and SERCA ATPases, there is not yet a
way to visualize the location of this part of Pma1. It is worth noting,
however, that the model of Fig. 7 places V665 and L678 on one side of
the protein while Tyr-689 lies at the base of a cavity on the opposite
side. Thus, the dephosphorylated C terminus may shield one (Y689C) or
two (V665C and L678C) of these residues directly, but it would have difficulty shielding all three. At least part (and possibly all) of the
glucose-dependent labeling by Alexa-488 may therefore
result from a primary conformational change elsewhere that indirectly exposes V665C, L678C, and Y689C to the aqueous medium.
There is a further reason to be interested in one of these residues:
Y689C, which lies at the interface of stalk segment 5 with the
membrane. Although the Y689C mutant ATPase is labeled by Alexa-488 in a
glucose-dependent way (see above) it is constitutively active even in the absence of glucose (12). The labeling result indicates that the mutant enzyme can still respond conformationally to
glucose; for example, the C terminus may restrict the access of
Alexa-488 to Y689C when it is dephosphorylated (in the absence of
glucose) but may shift position to allow access when it is phosphorylated (in the presence of glucose). At the same time, the
constitutive nature of the Y689C mutation means that the
starvation-induced conformational change is no longer able to
down-regulate ATPase activity, perhaps because the mutated version of
S5 can no longer interact in an inhibitory way with the P-domain.
Tyr-689 corresponds to Lys-758 in the SERCA Ca2+-ATPase,
where Sorensen and Andersen (27) found that substitution by Ile speeds
the dephosphorylation of the enzyme from E2P to E2 while simultaneously slowing the rate of
Ca2+ binding from E2 to
Ca2E1. Indeed, the same authors have since described complex kinetic changes resulting from mutations at 14 other positions in S5 of the SERCA ATPase, pointing to a more general
role of S5 in communicating between catalytic and transport sites
(28).
A recent paper by Soteropoulos et al. (29) provides
independent evidence for an important functional role of stalk segment 5 of the yeast Pma1 ATPase. In that study, the introduction of a
helix-disrupting proline at either of two positions (D676P or I684P)
destroyed the ability of the ATPase to support growth, as did the
deletion of Asp-676 or the insertion of one, two, three, or four Ala
residues following Asp-676. Cells bearing a glycine at position 676 were viable, but they were unable to grow in acetate-containing medium
at low pH. This conditional phenotype allowed the authors to select
second-site suppressors that could restore the growth of D676G under
acidic conditions. One of the resulting mutations (V562I) again pointed
to an interaction between S5 and the phosphorylation domain, while
others gave evidence of interactions with stalk segment 3 (E288K), the
small cytoplasmic loop between membrane segments 6 and 7 (V748I), and a
region close to the putative C-terminal phosphorylation sites (G888S).
In summary, the present study adds to knowledge of structure-function
relationships within the yeast Pma1 ATPase by revealing a
glucose-dependent change in stalk segment 5. The next step
will be to understand how this change is triggered (most likely by phosphorylation/dephosphorylation near the C terminus), and in turn,
how it is transmitted to the catalytic region and into the membrane.
The introduction of Cys residues along S5 and the ability to label six
of them specifically with Alexa-488 will provide useful tools for
future work along these lines.
 |
ACKNOWLEDGEMENTS |
We thank Valery Petrov for providing the 3C
construct and Anthony Ambesi, Brett Mason, and Silvia Lecchi for
helpful discussions.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant GM15761.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The on-line version of this article (available at
http://www.jbc.org) contains supplemental material.
To whom correspondence should be addressed. Tel.: 203-785-2690;
Fax: 203-737-1771.
§
Present address: Universidad Nacional Autonoma de Mexico,
Departamento de Bioquimica, Facultad de Medicina, Mexico, D.F., 04510 Mexico.
Published, JBC Papers in Press, August 6, 2002, DOI 10.1074/jbc.M206793200
2
V. Petrov, unpublished experiments.
 |
ABBREVIATIONS |
The abbreviations used are:
S5, stalk segment 5;
MES, 4-morpholineethanesulfonic acid;
NTA, nitrilotetraacetic acid;
HPLC, high performance liquid chromatography.
 |
REFERENCES |
| 1.
|
Lutsenko, S.,
and Kaplan, J. H.
(1995)
Biochemistry
34,
15607-15613[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Gradmann, D.,
Hansen, U. P.,
Long, W. S.,
and Slayman, C. L.
(1978)
J. Membr. Biol.
39,
333-367[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Serrano, R.,
Kielland-Brandt, M. C.,
and Fink, G. R.
(1986)
Nature
319,
689-693[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Serrano, R.
(1983)
FEBS Lett.
156,
11-14[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Portillo, F.
(2000)
Biochim. Biophys. Acta
1469,
31-42[Medline]
[Order article via Infotrieve]
|
| 6.
|
Portillo, F.,
Eraso, P.,
and Serrano, R.
(1991)
FEBS Lett.
287,
71-74[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Chang, A.,
and Slayman, C. W.
(1992)
J. Cell Biol.
115,
289-295[Abstract/Free Full Text] ]
|
| 8.
|
Goossens, A., De La,
Fuente, N.,
Forment, J.,
Serrano, R.,
and Portillo, F.
(2000)
Mol. Cell. Biol.
20,
7654-7661[Abstract/Free Full Text]
|
| 9.
|
Auer, M.,
Scarborough, G. A.,
and Kuhlbrandt, W.
(1998)
Nature
392,
840-843[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Zhang, P.,
Toyoshima, C.,
Yonekura, K.,
Green, N. M.,
and Stokes, D. L.
(1998)
Nature
392,
835-839[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Toyoshima, C.,
Nakasako, M.,
Nomura, H.,
and Ogawa, H.
(2000)
Nature
405,
647-655[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Miranda, M.,
Allen, K. E.,
Pardo, J. P.,
and Slayman, C. W.
(2001)
J. Biol. Chem.
276,
22485-22490[Abstract/Free Full Text]
|
| 13.
|
Eraso, P.,
and Portillo, F.
(1994)
J. Biol. Chem.
269,
10393-10399[Abstract/Free Full Text]
|
| 14.
|
Cid, A.,
Perona, R.,
and Serrano, R.
(1987)
Curr. Genet.
12,
105-111[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Nakamoto, R. K.,
Rao, R.,
and Slayman, C. W.
(1991)
J. Biol. Chem.
266,
7940-7949[Abstract/Free Full Text]
|
| 16.
|
Novick, P.,
Field, C.,
and Schekman, R.
(1980)
Cell
21,
205-215[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Wang, G.,
Tamas, M.,
Pascual-Ahuir, A.,
and Perlin, D. S.
(1989)
J. Biol. Chem.
271,
25438-25445[Abstract/Free Full Text]
|
| 18.
|
Ito, H.,
Fukuda, Y.,
Murata, K.,
and Kimura, A.
(1983)
J. Bacteriol.
153,
163-168[Abstract/Free Full Text]
|
| 19.
|
Ambesi, A.,
Allen, K. E.,
and Slayman, C. W.
(1997)
Anal. Biochem.
251,
127-129[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Perlin, D. S.,
Harris, S. L.,
Seto-Young, D.,
and Haber, J. E.
(1989)
J. Biol. Chem.
264,
21857-21864[Abstract/Free Full Text]
|
| 21.
|
Fiske, C. H.,
and SubbaRow, Y.
(1925)
J. Biol. Chem.
66,
375-400[Free Full Text]
|
| 22.
|
Stone, K. L.,
and Williams, K. R.
(1996)
in
The Protein Protocols Handbook
(Walker, J. M., ed)
, pp. 427-434, Humana Press, Totowa, NJ
|
| 23.
|
Lowry, O. H.,
Rosebrough, N. J.,
Farr, A. L.,
and Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-275[Free Full Text]
|
| 24.
|
Janknecht, R., De,
Martynhoff, G.,
Lou, J.,
Hipskind, R. A.,
Nordheim, A.,
and Stunnenberg, H. G.
(1991)
Proc. Natl. Acad. Sci.
88,
8972-8976[Abstract/Free Full Text]
|
| 25.
|
Petrov, V. V.,
and Slayman, C. W.
(1995)
J. Biol. Chem.
270,
28535-28540[Abstract/Free Full Text]
|
| 26.
|
Chiu, I.,
Davis, D. M.,
and Strominger, J. L.
(1999)
Proc. Natl. Acad. Sci.
96,
13944-13949[Abstract/Free Full Text]
|
| 27.
|
Sorensen, T. L.-M.,
and Andersen, J. P.
(1997)
J. Biol. Chem.
272,
30244-30253[Abstract/Free Full Text]
|
| 28.
|
Sorensen, T. L.-M.,
and Andersen, J. P.
(2000)
J. Biol. Chem.
275,
28954-28961[Abstract/Free Full Text]
|
| 29.
|
Soteropoulos, P.,
Valiakhmetov, A.,
Kashiwasaki, R.,
and Perlin, D. S.
(2001)
J. Biol. Chem.
276,
16265-16270[Abstract/Free Full Text] .0
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|